120 related articles for article (PubMed ID: 35820279)
1. Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.
Kim JA; Berlow NE; Lathara M; Bharathy N; Martin LR; Purohit R; Cleary MM; Liu Q; Michalek JE; Srinivasa G; Cole BL; Chen SD; Keller C
Biochem Biophys Res Commun; 2022 Sep; 621():101-108. PubMed ID: 35820279
[TBL] [Abstract][Full Text] [Related]
2. Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.
Weekes D; Kashima TG; Zandueta C; Perurena N; Thomas DP; Sunters A; Vuillier C; Bozec A; El-Emir E; Miletich I; Patiño-Garcia A; Lecanda F; Grigoriadis AE
Oncogene; 2016 Jun; 35(22):2852-61. PubMed ID: 26387545
[TBL] [Abstract][Full Text] [Related]
3. Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.
Fernanda Amary M; Ye H; Berisha F; Khatri B; Forbes G; Lehovsky K; Frezza AM; Behjati S; Tarpey P; Pillay N; Campbell PJ; Tirabosco R; Presneau N; Strauss SJ; Flanagan AM
Cancer Med; 2014 Aug; 3(4):980-7. PubMed ID: 24861215
[TBL] [Abstract][Full Text] [Related]
4. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma.
Zhou W; Zhu Y; Chen S; Xu R; Wang K
Mol Med Rep; 2016 Jan; 13(1):713-9. PubMed ID: 26648125
[TBL] [Abstract][Full Text] [Related]
6. CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.
Ran Q; Jin F; Xiang Y; Xiang L; Wang Q; Li F; Chen L; Zhang Y; Wu C; Zhou L; Xiao Y; Chen L; Wu J; Zhong JF; Li SC; Li Z
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20511-20516. PubMed ID: 31548420
[TBL] [Abstract][Full Text] [Related]
7. Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.
Baranski Z; Booij TH; Cleton-Jansen AM; Price LS; van de Water B; Bovée JV; Hogendoorn PC; Danen EH
J Pathol; 2015 Jul; 236(3):348-59. PubMed ID: 25757065
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
9. PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule.
Lund-Andersen C; Patzke S; Nähse-Kumpf V; Syljuåsen RG
Radiother Oncol; 2014 Feb; 110(2):355-61. PubMed ID: 24502970
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
11. Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
Narla ST; Lee YW; Benson CA; Sarder P; Brennand KJ; Stachowiak EK; Stachowiak MK
Schizophr Res; 2017 Jul; 185():17-32. PubMed ID: 28094170
[TBL] [Abstract][Full Text] [Related]
12. Evidence-Based Theory for Integrated Genome Regulation of Ontogeny--An Unprecedented Role of Nuclear FGFR1 Signaling.
Stachowiak MK; Stachowiak EK
J Cell Physiol; 2016 Jun; 231(6):1199-218. PubMed ID: 26729628
[TBL] [Abstract][Full Text] [Related]
13. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin.
He C; Sun J; Liu C; Jiang Y; Hao Y
Clin Epigenetics; 2019 Jan; 11(1):8. PubMed ID: 30651137
[TBL] [Abstract][Full Text] [Related]
14. Global Genome Conformational Programming during Neuronal Development Is Associated with CTCF and Nuclear FGFR1-The Genome Archipelago Model.
Decker B; Liput M; Abdellatif H; Yergeau D; Bae Y; Jornet JM; Stachowiak EK; Stachowiak MK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396256
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.
Labanca E; Yang J; Shepherd PDA; Wan X; Starbuck MW; Guerra LD; Anselmino N; Bizzotto JA; Dong J; Chinnaiyan AM; Ravoori MK; Kundra V; Broom BM; Corn PG; Troncoso P; Gueron G; Logothethis CJ; Navone NM
Eur Urol Oncol; 2022 Apr; 5(2):164-175. PubMed ID: 34774481
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of bisphosphonate and radiation on osteosarcoma cells.
Ryu K; Murata H; Koto K; Horie N; Matsui T; Nishigaki Y; Sakabe T; Takeshita H; Itoi M; Kimura S; Ashihara E; Maekawa T; Fushiki S; Kubo T
Anticancer Res; 2010 Jul; 30(7):2713-20. PubMed ID: 20683003
[TBL] [Abstract][Full Text] [Related]
18. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.
Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W
J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352
[TBL] [Abstract][Full Text] [Related]
19. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
20. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
